Summary.-Transformation of primary hamster embryo cells was investigated using 3-methylcholanthrene (MCA), a combination of MCA and 12-0-tetradecanoylphorbol-13-acetate (TPA), and initiation with MCA or dibenz(a,h)anthracene (DBA) followed by promotion with TPA. Evidence for transformation was (a) abnormal cellular morphology, (b) increased lifespan, (c) growth in soft agar, and (d) tumour induction by s.c. inoculation into suckling hamsters.
THE ABILITY of promoting agents to enhance the formation of tumours in mouse skin by carcinogens has been reviewed by Boutwell (1964 Boutwell ( , 1974 . In vitro effects of 12-0-tetradecanoyl-phorbol-13-acetate (TPA) on cellular multiplication, RNA synthesis and DNA repair synthesis have been studied in mouse fibroblasts (Sivak & Van Duuren, 1970; Sivak et al., 1969 Sivak et al., , 1972 Trosko et al., 1975) . More recently, TPA has been shown to enhance the focal transformation rate of mouse C3H/1OT1/2 cells and to enhance transformation in rat fibroblasts in culture (Lasne et al., 1974 (Lasne et al., , 1977 . The rate of focal transformation in mouse cells could be increased or decreased, depending * To whom requests for reprints should be sent. on the time at which TPA was administered relative to the carcinogen . Our studies were undertaken to determine whether application of the promoting agent, TPA, would reduce the time from treatment with a carcinogen to the appearance of neoplastic transformation of hamster embryo cells in vitro.
Since TPA can alter the morphology of human, mouse and chick cells (Sivak, et al., 1969; Diamond et al., 1974) 
DISCUSSION
Using hamster embryo cells, we studied the effect of TPA treatment on malignant transformation. Parameters measured included: morphological transformation, increased lifespan, growth in soft agar and induction of tumours in animals. Our studies show that TPA can act either as an inhibitor or a promoter of malignant transformation in hamster embryo cells depending on the time interval between treatment with carcinogen and the administration of TPA. Similarly, TPA-dependent stimulation or inhibition of the rate of focal transformation of mouse fibroblasts (C3H/10T 1/2) cells was shown to depend upon the length of time between carcinogen and TPA treatments . When the hamster cells were treated with MCA or MCA+TPA, morphological transformation was observed at the same time irrespective of treatment. Similarly, all the groups showing morphological transformation grew beyond the lifespan of the control cultures. However, induction of tumours in animals did not occur until 20 PD later with the lowest TPA concentration, and 44 PD later with the highest TPA concentration. Similar observations were made concerning growth in soft agar. When TPA was administered simultaneously with MCA, criteria indicative of malignant transformation were inhibited.
Treatment with TPA 7 days after MCA produced complete inhibition of both tumour formation and growth in soft agar. In contrast to our observations, others have shown that when TPA was applied 3-5 days after carcinogen treatment in mouse cells or 7 days after carcinogen treatment in rat cells (Lasne et al., 1977) or rat cells (Lasne et al., 1977 Morphological changes appeared to reflect the initial events in transformation that are followed later by tumorigenesis and growth in soft agar. The studies reported here indicate that cells become tumorigenic before they acquire the ability to grow in soft agar (Tables I and  II) . This confirms the use of the generally observed in vitro characteristic of growth in soft agar as a valid indicator of the tumorigenic potential of cells. The inhibitory effects of TPA on characteristics of transformation may also occur through an inhibition of the mechanisms responsible for invasive properties of the transformed cells. The use of TPA in combination with MCA or DBA on hamster embryo cells to delay the appearance of malignant characteristics provides a model system for studying the sequence of events from morphological transformation to tumourigenieity. 
